Skip to main content

Table 3 Comparison of endpoint events stratified by the AIP and GA

From: The combined predictive power of the atherogenic index of plasma and serum glycated albumin for cardiovascular events in postmenopausal patients with acute coronary syndrome after percutaneous coronary intervention

Variables

n (%)

Total

AIP-L + GA-L

(n = 324)

AIP-H + GA-L

(n = 329)

AIP-L + GA-H

(n = 335)

AIP-H + GA-H

(n = 317)

P value

CVE

98 (7.5)

9 (2.8)

22 (6.6)

26 (7.9)

41 (12.9)

< 0.001

Cardiac death

16 (1.2)

1 (0.3)

2 (0.6)

4 (1.2)

9 (2.8)

0.017

Nonfatal MI

70 (5.4)

8 (2.5)

17 (5.1)

18 (5.5)

27 (8.5)

0.009

Nonfatal stroke

19 (1.5)

1 (0.3)

3 (0.9)

5 (1.5)

10 (3.2)

0.018

  1. AIP, atherogenic index of plasma; GA, glycated albumin; AIP-L + GA-L, lower AIP level + lower GA level; AIP-H + GA-L, higher AIP level + lower GA level; AIP-L + GA-H, lower AIP level + higher GA level; AIP-H + GA-H, higher AIP level + higher GA level; MI, myocardial infarction